Skip to main content
Premium Trial:

Request an Annual Quote

Alnylam Licenses siRNA IP to Bio-Rad

NEW YORK (GenomeWeb News) — Alnylam Pharmaceuticals today said it has granted Bio-Rad non-exclusive rights to sell RNAi products based on certain of its IP.
 
The license falls under Alnylam’s Kreutzer-Limmer patent family, which covers the use of small interfering RNAs and “their use to mediate RNAi in mammalian cells,” the RNAi drug maker said.
 
Financial terms of the agreement were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.